Altre lingue Metropolis Healthcare Limited

Azioni

METROPOLIS

INE112L01020

Prestatari di assistenza sanitaria

Prezzo di chiusura NSE India S.E. Altri mercati azionari 10/02/2026			Variaz. 5gg	Var. 1 gen.
2.005,60 ^INR	+0,31%		+5,32%	+3,98%

06/02	Kalpataru Limited nomina Gajendra Mewara come Segretario Aziendale e Responsabile della Conformità, con effetto dal 6 febbraio 2026	CI
05/02	Metropolis Healthcare Limited, Q3 2026 Earnings Call, Feb 05, 2026

Altre lingue

06/02	Kalpataru Limited Appoints Gajendra Mewara as Company Secretary and Compliance Officer, Effective February 6, 2026
04/02	Metropolis Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
04/02	Metropolis Health Dec-quarter consol net profit 413.9 million rupees
04/02	Diary-India economic, corporate events on February 4
13/01	Metropolis Healthcare Limited Launches Centre of Genomics to Scale Precision Diagnostics and Advance Research in India
05/01	Metropolis Health standalone revenue growth at 15% YoY
04/11	Metropolis Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
04/11	Metropolis Healthcare Limited Approves a Dividend
07/10/25	Financials lead Indian equity benchmarks higher for fourth session
19/09/25	Metropolis Healthcare Completes Acquisition of Ambika Pathology Laboratory in Kolhapur; Shares up 3%
18/09/25	Metropolis Healthcare buys Ambika Pathology Laboratory
18/09/25	Metropolis Healthcare Limited completed the acquisition of Ambika Pathology Laboratory from Rajendra Sadashiv Patil.
16/09/25	Metropolis Healthcare Incorporates Wholly-Owned Subsidiary
16/09/25	Metropolis Healthcare Limited Incorporates Wholly Owned Subsidiary Metropolis Quality Solutions Private Limited
07/08/25	Metropolis Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
07/08/25	Metropolis Healthcare Limited entered into a business transfer agreement to acquire Ambika Pathology Laboratory from Rajendra Sadashiv Patil for INR 170 million.
18/07/25	Metropolis Healthcare says Sushil Shah steps down as chairman emeritus
11/07/25	Indian Indices Extend Losses on Profit-Taking, Global Trade Tensions
10/07/25	Indian Shares Slump Despite Potential US Trade Talks
09/07/25	Indian Stocks Dip Over Trump's Announcement of Copper Tariffs
04/07/25	Metropolis Healthcare says Q1FY26 revenue growth approx. 23% y-o-y
18/06/25	Metropolis Healthcare Limited Appoints Dr. Monika Prabhakar as "Group Head Lab Operations" Effective from June 19, 2025
17/06/25	Metropolis Healthcare Unit Acquires Scientific Pathology Business
17/06/25	Metropolis Healthcare Says Subsidiary Buys Dr. Ashok Kumar Sharma's Scientific Pathology
02/06/25	Metropolis Healthcare Extends Timeline for Scientific Pathology Acquisition by 15 Days

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Articoli MarketScreener Analisi MarketScreener Idee di trading

Altre lingue Metropolis Healthcare Limited

Azioni

METROPOLIS

INE112L01020

Prestatari di assistenza sanitaria

Altre lingue

Filtri